Publicacións en colaboración con investigadores/as de Complejo Hospitalario Universitario de Albacete (94)

2024

  1. T-reg transcriptomic signatures identify response to check-point inhibitors

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  2. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031

2022

  1. Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  2. Characteristics, Acute Results, and Prognostic Impact of Percutaneous Coronary Interventions in Spontaneous Coronary Artery Dissection (from the Prospective Spanish Registry on SCAD [SR-SCAD])

    American Journal of Cardiology

  3. ERK5 Is a Major Determinant of Chemical Sarcomagenesis: Implications in Human Pathology

    Cancers, Vol. 14, Núm. 14

  4. Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers

    Cancers, Vol. 14, Núm. 18

  5. Genomic mapping of copy number variations influencing immune response in breast cancer

    Frontiers in Oncology, Vol. 12

  6. Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis

    Therapeutic Advances in Medical Oncology, Vol. 14

2021

  1. Clinical Outcomes After Implantation of Polyurethane-Covered Cobalt-Chromium Stents: Insights from the Papyrus-Spain Registry

    Cardiovascular Revascularization Medicine, Vol. 29, pp. 22-28

  2. Genomic mapping of splicing-related genes identify amplifications in lsm1, clns1a, and ilf2 in luminal breast cancer

    Cancers, Vol. 13, Núm. 16

  3. Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia

    Leukemia, Vol. 35, Núm. 8, pp. 2358-2370

  4. In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer

    Cellular Oncology, Vol. 44, Núm. 3, pp. 569-580

  5. MZ1 co-operates with trastuzumab in HER2 positive breast cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

  6. Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials

    Hematological Oncology, Vol. 39, Núm. 4, pp. 529-538

  7. ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology, Vol. 77, Núm. 17, pp. 2187-2199

  8. Transcriptomic profiles of cd47 in breast tumors predict outcome and are associated with immune activation

    International Journal of Molecular Sciences, Vol. 22, Núm. 8

2020

  1. An overview of antibody conjugated polymeric nanoparticles for breast cancer therapy

    Pharmaceutics, Vol. 12, Núm. 9, pp. 1-20

  2. Antibody conjugation of nanoparticles as therapeutics for breast cancer treatment

    International Journal of Molecular Sciences, Vol. 21, Núm. 17, pp. 1-21

  3. Checkpoint kinase 1 pharmacological inhibition synergizes with dna-damaging agents and overcomes platinum resistance in basal-like breast cancer

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-14